The Institute for Regenerative and Cellular Medicine (IRCM) is a 501(3)(C) non-profit corporation created to validate regenerative and cellular medicine through Institutional Review Board (IRB) certification as well as collaborative and translational research. The IRB IRCM houses is registered with the U.S. Department of Health and Human Services (HHS), with a primary goal of providing ethical oversight of research to insure patient safety and the effectiveness of clinical protocols. The IRCM IRB is composed of a select group of PhDs with a background in stem cell research, physicians who work in the field, patient advocates, and professional privacy and regulation experts—all of whom are registered with the FDA.

IRCM IRB functions as full-time external IRB for Seraph Research Institute and oversees all the translational and clinical studies conducted.